The antiangiogenic effect of miR-223-3p is corroborated by observations made on tumor tissue from HNSCC patients, thus indicating that areas of high miR-223-3pexpression displayed low CD31 IHC staining, and vice versa (Figure 4C and Table 1). The gene discussed is PECAM1; the disease is head and neck squamous cell carcinoma.